Brian Piper

CIK 1665924 · EVP, Chief Financial Officer · last filed 2026-02-18

Brian Piper is an EVP, Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for SANA, was dated Feb 18, 2026. Across all open-market trades the lifetime net is −$563.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$37.4K

Companies

4

Total Filings

10

Lifetime Open-Market Net

-$563.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SANA EVP, Chief Financial Officer $2.68 $0 1 2026-02-18
PRLD Chief Financial Officer 8,333 $4.49 $37.4K -$563.4K 3 2021-08-27
Aevi Genomic Medicine, LLC (GNMX) Delisted CFO & Corporate Secretary $0 5 2018-06-18
Aevi Genomic Medicine, LLC (MDGN) Delisted Chief Financial Officer $0 1 2016-04-19

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-18 SANA Grant (A) $0 EDGAR
2021-08-27 PRLD Mixed -$262.1K EDGAR
2021-07-22 PRLD Grant (A) $0 EDGAR
2021-05-27 PRLD Mixed -$269.8K EDGAR
2018-06-18 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2018-05-16 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2018-05-16 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2017-08-15 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2017-02-17 Aevi Genomic Medicine, LLC (GNMX) Delisted Grant (A) $0 EDGAR
2016-04-19 Aevi Genomic Medicine, LLC (MDGN) Delisted Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.